NCT01815099

Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder

Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder: Substudy #2

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 4 (actual)
• Sponsor: Hartford Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

We are investigating the feasibility and efficacy of transcranial magnetic stimulation (TMS) for patients with GAD who were placebo nonresponders in DIEF003523.1.

Detailed description

We expected to enroll five patients with GAD who failed to respond to a sham (placebo) TMS intervention. In this pilot study we enrolled three participants into a protocol including 10 rTMS sessions (twice a week for five weeks) and one into a protocol including 15 rTMS sessions (three times a week for five weeks). Assessments occurred at pretreatment and at posttreatment.

Conditions

• Generalized Anxiety Disorder

Interventions

Type	Name	Description
DEVICE	rTMS Treatment	Either 10 or 15 rTMS sessions (2 or 3 times/week for 5 weeks, respectively)

Timeline

• Start date: 2014-05-01
• Primary completion: 2015-08-01
• Completion: 2015-08-01
• First posted: 2013-03-20
• Last updated: 2017-04-10
• Results posted: 2017-04-10

Locations

1 site across 1 country: United States